|
| | SR0494 | | LRB104 16014 LAW 29267 r |
|
|
| 1 | | SENATE RESOLUTION |
| 2 | | WHEREAS, Pancreatic cancer is one of the deadliest types |
| 3 | | of cancer, possessing a devastating five-year survival rate |
| 4 | | below 13%; and |
| 5 | | WHEREAS, Early detection offers the best chance to improve |
| 6 | | survival, but symptoms are often vague and appear late, and |
| 7 | | most patients are diagnosed at advanced stages; and |
| 8 | | WHEREAS, More than 64,000 new cases of pancreatic cancer |
| 9 | | are projected in the U.S. for 2025, with rates rising among |
| 10 | | younger adults; and |
| 11 | | WHEREAS, Established national guidelines exist for |
| 12 | | individuals at high risk, specifically those with certain |
| 13 | | inherited, or germline, mutations or a significant family |
| 14 | | history of pancreatic cancer, and these individuals may |
| 15 | | benefit from specialized surveillance in dedicated high-risk |
| 16 | | clinics; and |
| 17 | | WHEREAS, Despite these recommendations, pancreatic cancer |
| 18 | | awareness among patients and providers remains low, and many |
| 19 | | at-risk individuals are not connected to the care that could |
| 20 | | help detect cancer earlier; and |